Billings Clinic
Especially For:

Clinical Trials

Title   N0872 recurrent Gliioblastoma
Description   NCCTG N0872 Phase I/Randomized Phase II Double Blind Study of Either Dasatinib or Placebo Combined with Bevacizumab in Recurrent Glioblastoma (Study 2)
IRB Number   N0872
Category   Brain
Status   Active
Start Date   05/21/2012
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Judy Miller RN
Contact Email   jmiller4@billingsclinic.org
Phone   (406) 435-7482
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.